The Dubai Health Authority held a workshop recently at the Emirates Towers in Dubai with more than 100 key healthcare stakeholders, including health providers and technology partners, to discuss the Dubai Digital Health Strategy.

The strategy, which is in its finalisation stages, aims to deliver patient-centric and data-driven healthcare services, regulation and integration through digital innovation.

Related: Dubai: A thriving healthcare business destination

The workshop presented an opportunity to provide a detailed overview of the strategy and an opportunity for stakeholders to provide their feedback prior to the finalisation of the strategy for the health sector of Dubai.

Ahmed Al Nuaimi, CEO of the Corporate Shared Support Services Sector at the DHA, expressed his thanks and appreciation to the health sector for their support and contribution towards finalising this key strategy.

Related: Patient Talk Podcast: NABIDH, an innovative Health Information Exchange in Dubai

Al Nuaimi emphasised that collaboration is a key component for the success of this strategy and that building a digital ecosystem for the health sector is in line with the Emirate’s digitisation strategy that aims to provide the highest quality of services to community members.

Al Nuaimi said: “In Dubai, we are implementing digital transformation across the full spectrum of healthcare, from telemedicine to e-claims, disease surveillance and management, as well as electronic health records and health information exchange. We aim to harness the power of technology to transform the way healthcare services are delivered in Dubai and to provide patients with the highest quality of patient-centred and personalised care.”

Dr. Nahed Monsef, Director of the Strategy & Governance Department DHA said: “A digital strategy provides a detailed framework to help us achieve digital transformation across all areas of the health sector from healthcare management and processes to patient services so that we can best utilise technology to further bolster the health system and provide the highest quality of care to our patients. The Dubai Digital Health Strategy will enable and empower the population of Dubai to better manage their health and well-being by establishing connectivity between digital technologies and health-related sciences.”

Objectives of the strategy include:

• Digitising the patient journey across the continuum of care
• Defining governance framework, legislations and policies for digital health.
• Maximising interoperability of healthcare systems
• Utilising robust up-to-date infrastructure
• Utilising advanced information management, data analytics and AI
• Leading the field of Digital Health Research and Development
• Establishing a Digital Health ecosystem by empowering a digital community and creating platforms for human capital training and planning

Dr. Mohammad Al Redha, Director of DHA’s Health Informatics and Smart Health Department, said: “A digital strategy in healthcare will benefit the health sector, enhance patient delivery and provide data to plan effective evidence-based population health and disease prevention strategies. At the same time, it will empower patients with  digital tools to track their health and wellbeing.”

NABIDH initiative

One such initiative in the pipeline is the NABIDH initiative, which is the electronic medical record initiative for the Emirate of Dubai that provides patients and their healthcare professionals access to an electronic medical record. The file provides a complete snapshot of the patient’s medical history and flags allergies. The project is linked to UAE’s Riyati initiative, ensuring that in future, every person in the UAE has one electronic medical file.

At the event, 52 hospitals in the Emirate were felicitated for onboarding the NABIDH initiative. This means, presently, 100 per cent of hospitals in Dubai are integrated with the NABIDH system and by the end of this year, all clinics in the Emirate will also be a part of this system.

Al Redha said: “NABIDH is a key initiative in our healthcare digitisation journey. We are proud of the collaboration with health facilities across the public and the private health sector to help us achieve this vision and further enhance the health sector in Dubai.”

Al Redha added that NABIDH enables central storage and secure exchange of patient health information between healthcare professionals.

For patients, it means that their healthcare provider will have one electronic medical file with all their medical reports safely stored and that when the patient moves from one facility to another, the medical file will follow.

Al Redha said that all these pioneering initiatives will be part of the larger framework of the Dubai Digital Health Framework. “At the end of the day, our priority is patient care and wellbeing. Digitisation of health services not only benefits the health sector by reducing costs and improving efficiencies but also ensures patients are empowered, helps in the delivery of patient-centred care and an end-to-end seamless patient experience across the complete continuum of care.”

Back to Management

The World Health Organization (WHO) states that half of tobacco users die due to an illness caused by it. Seven million people die directly from tobacco use yearly, and close to 22.3 per cent of the global population uses tobacco products. In response, governments worldwide have begun to clamp down on tobacco use.  

In 2003, 182 countries adopted the WHO Framework Convention on Tobacco Control (WHO FCTC) to address the growing use of tobacco products. Some of the critical measures that governments adopt include reducing exposure to second-hand smoke, pictorial health warnings, high rates of taxes, and awareness campaigns that encourage quitting tobacco. A few countries have gone a step ahead. They have started implementing various degrees of bans on tobacco use.  

Related: Smoking cessation crucial for post-COVID-19 recovery

On the occasion of this World No Tobacco Day (WNTD), let’s look at some cautionary regulations addressing the tobacco epidemic.  

What countries across the world are doing to combat tobacco use? 

On May 11, 2023, Portugal put forward legislation that seeks to ban smoking in most outdoor areas, including covered terraces. In addition, heated tobacco products used in vaping devices and e-cigarettes will now be on par with conventional tobacco. The country also seeks to restrict tobacco sales so that by 2040, it can raise a tobacco-free generation.  

Related: Why you need to kick your tobacco habit

Last year, New Zealand passed a unique law that effectively outlaws smoking for the next generation. Although conventional cigarette consumption is likely to diminish, the country does not attempt to prohibit vaping. In fact, 8.3 per cent of adults in New Zealand have now taken to vaping.  

In Australia, indoor smoking is outlawed in all states and territories, but the laws are less stringent in outdoor areas. In 2018, the country set up the Illicit Tobacco Taskforce (ITTF) to address the illegal tobacco trade. Unlike its neighbour, e-cigarettes, and vaping are banned in Australia.  

The Middle East presents a dismal picture of tobacco use. Lebanon is the highest consumer of tobacco products in the region. The number of cigarettes smoked per person per year in Lebanon is 1,955, whereas in Kuwait and Libya are 1,849 and 1,764, respectively. In the UAE, the number is reportedly 438 cigarettes per annum per capita.  

Although there is a growing awareness about the harmful effects of cigarettes and chewable tobacco, vaping seems to have become popular among youngsters, which needs to be addressed sooner than later.  

Vaping devices are a Trojan horse 

Despite cigarettes falling out of favour worldwide, there is a steady increase in the use of vaping devices. A vaping device is a handheld device that allows the user to breathe in a mist of heated nicotine.  

Although the potential long-term effects of vaping are unknown, the 2019 E-cigarette or Vaping Use-Associated Lung Injury (EVALI) outbreak highlighted how harmful it could be, even in the short term. Multiple studies show that vaping can cause lung inflammation and injury and may have cardiovascular consequences.  

On this World No Tobacco Day (WNTD), we must pause and divert our attention to vaping devices, which are becoming increasingly popular among the youth. 

Back to Management

The inclusions and use of technological advancements in mental healthcare make health services more accessible, say experts. 

As Mental Health Awareness Month of May is marked globally, healthcare professionals and experts, while shedding light on the latest technological advancements in mental healthcare, say that technology supports individuals in navigating the challenges of anxiety. 

Related: How are digital therapeutics improving mental health outcomes?

Nesma Luqman, Clinical Psychologist at the Priory Wellbeing Centre

 

Related: How wearables can help support mental health and well-being

The Priory Wellbeing Centre in Abu Dhabi, renowned for its expertise in mental health, has emphasised the significance of incorporating technology into the fast-paced hospital environment. Nesma Luqman, a Clinical Psychologist at the Priory Wellbeing Centre, stated, "Technological advancements such as teletherapy, mental health apps, wearable technology, and Artificial Intelligence/Machine Learning are transforming mental health care for healthcare professionals in high-risk settings.” 

She said telepsychiatry enables remote psychiatric care through video conferencing, allowing healthcare staff to receive support despite their demanding schedules.  

“Mental health apps offer resources for stress management and mindfulness, designed specifically to cater to the needs of healthcare professionals. Furthermore, wearable technology provides real-time data on indicators of stress and anxiety, enabling early intervention and prevention. AI/ML technologies analyse large datasets to personalise treatment plans based on individual requirements, enhancing patient outcomes and staff well-being,” she added. 

This year's Mental Health Awareness Month focuses on anxiety, a prevalent issue affecting millions worldwide. Mohamad Naamani, a Clinical Psychologist at the Priory Wellbeing Centre, highlighted the impact of anxiety disorders, stating, "Anxiety disorders are the most common mental illness in the US, affecting 40 million adults annually. In the UAE, a study by Mahmoud and Saravanan in 2020 revealed that 56.4 per cent of the sample struggled with anxiety.” 

Mohamad Naamani, Clinical Psychologist at the Priory Wellbeing Centre

 

He also said that the emergence of telehealth technology is revolutionising mental healthcare by providing virtual access to psychiatrists, therapists, and other mental health professionals via video conferencing or calls, enabling patients and other professionals to connect easily.  

“This technology is particularly advantageous in areas where mental health professionals are scarce, as it enables access to care regardless of location. Mobile apps and online therapy platforms can also provide quick and convenient access to mental health resources and support,” he added. 

The experts provided tips to help individuals manage anxiety, including deep breathing, meditation, and progressive muscle relaxation techniques to help induce relaxation and alleviate anxiety symptoms. They also said regular exercise has been proven to improve well-being and reduce anxiety.  

“Adequate sleep is crucial, as sleep deprivation can worsen anxiety symptoms. It is also important to limit caffeine and alcohol consumption, as they can exacerbate anxiety. Practising mindfulness by staying present in the moment can aid in reducing anxiety symptoms. Maintaining social connections and seeking support from loved ones can alleviate anxiety. Professional help should be sought if anxiety symptoms interfere with daily life, as mental health professionals can provide effective tools and strategies,” said Nesma. 

Nesma also stressed the importance of patience and perseverance in managing anxiety, stating, “Finding a healthy balance takes time, and it is crucial to be patient with oneself.” She encouraged individuals to seek professional help if needed, emphasising that seeking support is a sign of strength. 

Back to Technology

May 30 marks World Multiple Sclerosis (MS) Day, a global occasion aimed at raising awareness about this neurological disease and supporting those affected by it.  

However, despite its impact on millions of people worldwide, MS remains underreported, and there are significant limitations in access to and barriers to effective MS management. Health leaders are now being called upon to enable change and address these issues. 

Related: Connection is key to supporting multiple sclerosis patients

The National Multiple Sclerosis Society (NMSS) of the UAE has taken a proactive approach to support the local community affected by MS. Recently launched initiatives by the NMSS include MS Strong, a health and well-being partnership programme, and New to MS, an ongoing webinar series targeting those recently diagnosed with MS in the region. 

MS Strong offers complimentary health and well-being classes designed to keep individuals affected by MS as active as possible, considering their specific conditions. These classes cater to a wide range of physical abilities, including options for participants who need to remain seated or use a wheelchair.  

Related: The future of UAE healthcare is preventive, predictive, and precision-led

The New to MS programme provides online access to leading medical professionals specialising in MS. The programme aims to support individuals who have recently been diagnosed with the disease, as this can be a challenging and overwhelming time.  

MS is a neurological disease that disrupts the flow of information between the brain and the body. It primarily affects young adults, causing a wide range of symptoms such as numbness, tingling, mood changes, memory problems, pain, fatigue, and even paralysis. Women are three times more likely to develop MS than men, and the disease is typically diagnosed in young adulthood, between the ages of 20 and 40. The unpredictable and disabling nature of MS presents significant physical, emotional, and mental health challenges for those affected. 

Speaking about the initiatives leading up to World MS Day, Dr. Fatima Al Kaabi, vice chair of the NMSS, highlighted the significance of raising awareness about MS in the UAE and the global community. She emphasised the importance of offering support during the early stages of diagnosis, which can often be daunting. 

According to studies, MS affects over 2.8 million people worldwide. In the UAE, 2,000 individuals have been diagnosed with the disease, but the actual number of people living with MS is believed to be significantly higher. To address this, the Department of Health, Abu Dhabi, and the NMSS are focused on raising awareness and promoting early diagnosis and treatment to improve long-term health outcomes and reduce the number of relapses. 

To enable change and address the underreporting of MS, health leaders need to prioritise raising awareness, improving access to medical expertise, and breaking down barriers to effective MS management.  

Dr. Khalid Al Saffar, Specialist Neurologist at Medcare Hospital, Al Safa, said, “The disease starts with numbness. It may not be diagnosed by a general practitioner and may be neglected or under reported.” 

He also said that medication for MS is expensive, and availability is an issue. “Medication cost is a barrier to management. Patients should have access to physiotherapy, education, and MS rehabilitation centres are important to make disease management easy,” he said. 

Through collaboration and continued efforts, it is hoped that the impact of MS can be mitigated and individuals affected by the disease can lead fulfilling lives, added Dr. Khalid. 

Back to Management

The personal cost of a stroke is immeasurable, as anyone who has lost a loved one or knows a survivor can attest. The devastating effects of stroke can include loss of mobility, impaired brain function and communication, chronic fatigue, depression, and memory loss. This year alone, 12.2 million people worldwide are projected to have their first stroke, and 6.5 million will die as a result. These sobering statistics emphasise the importance of preventive measures, early detection, effective treatment, and rehabilitation services in addressing the global impact of stroke.  

Stroke also comes at a financial cost that affects more than just patients and their immediate support networks. Beyond lost wages and out-of-pocket expenses incurred by stroke survivors and their families, there is also the wider economic cost that inhibits sustainable development in markets already grappling with the complexities of delivering primary health care. Annually, the cost of stroke treatment, rehabilitation, and indirect expenses is estimated to exceed US$700 billion. If current trends persist, the economic impact of stroke on a global scale is conservatively set to exceed US$1 trillion by 2030.  

The diagnostics investment landscape 

Related: Updated guidelines make stroke management easier

Public health initiatives, investment in stroke care infrastructure, advancements in medical technology, and research efforts are crucial in reducing the burden of stroke on global healthcare systems and improving patient outcomes. Globally, the estimated return on investment for every US$1 spent on preventing stroke and cardiovascular disease is US$10.90. The global stroke diagnostic and therapeutic market size was valued at US$32.69 billion in 2021 and is predicted to hit over US$65.45 billion by 2030. In the Middle East, the stroke diagnostics market is expected to reach US$222.27 million by 2028.  

In the United Arab Emirates, between 8,000 and 10,000 individuals experience a stroke each year. Globally, 80 per cent of stroke victims are aged 65 or older, but in the UAE, nearly 50 per cent of stroke patients are under the age of 45.  

Related: Atrial Fibrillation: A silent condition that increases risk of stroke by five times

“According to the World Health Organization, one in four people runs the risk of having a stroke in their lifetime. In the UAE, about 25 per cent of adults have hypertension, which puts our population at greater risk of having a stroke,” says Dr. Khalil Zahra, Chief of Neuro-Interventional Surgery at the Neurological Institute of Cleveland Clinic Abu Dhabi. “Here, stroke is the leading cause of disability and the third leading cause of death. It has never been more crucial to have the most innovative technology available for treating patients.” 

Precision healthcare in the race against the clock 

Multiple high-tech examples abound: Saudi Arabia’s Seha Virtual Hospital, which connects patients to a network of medical experts across 130 hospitals; SSMC Abu Dhabi’s state-of-the-art angio suites; the UAE Ministry of Health and Prevention’s (MoHAP) neurorehab center’s virtual reality physiotherapy; and more. The region has made massive strides in using technology to speed up stroke detection and diagnosis in recent years.  

“One thing about the MENA market is that they generally tend to adopt technologies very fast. Innovation is happening in leaps and bounds, so there are new systems, tools, and techniques every six months that continue to improve precision and quality,” says Dr. Malathi Arshanapalai, Chief Medical and Quality Officer at Aster DM.  

Investing in high-end equipment has an inherently high capex cost, so replacing it every six months is hardly feasible. In most cases, it’s not required, she explains. When investing in precision care, Arshanapalai says that hospitals need to analyse what is in the best interest of the patients. “Every institution should consider a financial study that looks at precision, quality, and speed. Of course, the technology also has to be affordable for patients, so it depends on the numbers. Weighing the pros and cons and bearing in mind the speed with which you can diagnose (conditions) accurately should be the prime criteria for investing in new technologies.” 

In 2022, Cleveland Clinic Abu Dhabi adopted the ARTIS Icono, an advanced stroke interventional system that works with 2D and 3D imaging and artificial intelligence to speed up diagnostics and treatment. With victims of ischemic stroke, the most common type of stroke, timing is crucial. Rapid diagnosis and immediate medical treatment administered in less than 60 minutes, known as the ‘golden hour’, can reduce the chances of further complications. “Typically, we aim for a maximum of about six hours from symptom onset to perform a neuro-thrombectomy, a procedure that dissolves the clot in a patient’s brain,” adds Zahra.  

Traditional stroke intervention begins with a CT scan, and surgeons manually study the data before operating to break the blood clot. Using AI to provide high-resolution medical imaging for greater visibility, surgeons can immediately start treatment without needing a CT scan.  

“Improving the visualisation of bleedings that occur anywhere in the cranial area can make it possible to skip prior conventional imaging for certain patients with a suspected stroke, which means that these patients can be taken directly to the angio lab for diagnosis and treatment, shortening the lead time before the vascular occlusion is removed,” says Michael Scheuering, Head of Interventional Radiology at Siemens Healthineers, the company behind ARTIS Icono. “Any time saved in treating strokes can mean the difference between living independently and living in a wheelchair.” 

Computer-orchestrated thrombectomy is another ground-breaking advancement in the treatment of stroke. California-based health tech firm Penumbra developed the Lightning Flash mechanical thrombectomy system to remove venous and pulmonary clots more quickly and safely than earlier tools. For improved clot removal speed while still minimising blood loss, the most recent version now has two algorithms—one for pressure and one for flow. The company aims to break US$1 billion in annual revenue for the first time in 2023 with its slated launch of more computer-aided aspiration products for arterial clots and ischemic strokes. Currently, this technology is only available in the US and Europe, but it has potential in the Middle East as an early adopter of medtech. 

Technology to support preventative care  

Over 80 per cent of current stroke cases are preventable by lifestyle adjustments, says Dr. Suhail Abdulla Al Rukn, Neurology Consultant and Stroke Specialist, and President of the Middle East Stroke Management Organization. The first step in taking preventative action against stroke is to identify the risk factors, which may include rising diabetes, hypertension, and a high body mass index. The increased prevalence of these diseases causes several complications, such as atrial fibrillation, irregular blood flow, and a propensity for blood clotting, which calls for immediate detection and treatment to reduce the likelihood of stroke occurrence. 

A stroke happens when there is an interruption or reduction in the blood flow to a specific area of the brain, depriving the brain's tissue of oxygen and nutrients. Brain cells start to degenerate within minutes. The most prevalent cardiac arrhythmia (irregular heartbeat) is atrial fibrillation (AF), which also has a significant impact on stroke risk. Blood can accumulate in the atria, the upper chambers of the heart, and cause blood clots when atrial fibrillation is present. If a blood clot forms, it may move from the heart to the brain, blocking blood flow and leading to a stroke. 

“To address this, the medical community focuses on making the right choice for patients when it comes to stroke prevention through the use of oral anti-coagulants (blood thinners), which are used to treat atrial fibrillation. Studies have shown that anticoagulation can result in a 64 per cent reduction in strokes,” says Al Rukn.   

Mobile stroke units, telestroke and dedicated centres  

Developing dedicated stroke care centres will directly lead to faster and better patient outcomes, says Al Rukn. “Having such centres will decrease the mortality rates, complications, and outcomes of stroke. This is because patients lose about 120 million brain cells within one hour of suffering from a stroke incident. The underlying aim here is to deliver the right patient to the right medical facility in the right time frame.” Within two years since its implementation, Rashid Hospital has succeeded in reducing the door-to-needle time frame from 95 minutes to 35 minutes, says Al Rukn.   

Accessibility is crucial in the race against the clock, so implementing stroke units within hospitals has the potential to reduce the burden of stroke disability and ensure that lives are not lost as a result of not being able to reach the nearest center on time. The global benchmark for thrombolysis rates is an average of 18 to 20 per cent. This is where telestroke and mobile units have proven their success in increasing patient accessibility in urban areas. A four-year study by UTHealth demonstrates that stroke patients who are transported via a mobile stroke unit receive treatment 10 minutes faster than when they are transported via an ambulance. 

Mobile stroke units can be dispatched to the scene, where a portable CT scanner can image the patient's brain, providing immediate results to determine the course of treatment. The growing elderly population and the increasing prevalence of stroke conditions such as transient ischemic attacks are expected to drive the mobile stroke unit market, which is expected to reach $12.8 billion by 2027. However, current adoption is still limited globally by driving distances, times of operation, and worldwide availability. 

Public policies and regulations: A snapshot 

A multistakeholder study by the World Stroke Organization, World Health Organization, and Lancet Neurology Commission on Stroke reviewed the status of stroke services in low and middle-income countries (LMICs) compared to high-income countries. Of the 84 countries surveyed, seven in the Middle East scored higher than the global average for stroke prevention, acute care, and rehabilitation.   

However, one size doesn’t fit all when it comes to stroke care, especially in a region as diverse as the Middle East and North Africa with varying degrees of market maturity for stroke care. In order to improve stroke care and establish accreditation for existing programmes in the region, experts are calling for greater regional and international cooperation.  

Governments in the GCC region prioritise public health, including stroke prevention and awareness campaigns, says Dr. Zemer Wang, Medical Director at Aviv Clinics Dubai. He also credits the GCC’s diverse workforce as a boon for stroke care. “This expertise (in stroke care) facilitates the exchange of knowledge, best practices, and innovative approaches to stroke management,” he adds. 

In addition to stakeholder engagement and public awareness programs, establishing prospective registries and databases could provide valuable insights into the current state of prevention and acute stroke services in the region. “The GCC countries often collaborate on healthcare initiatives, including stroke care,” Wang explains. “They develop region-specific guidelines, protocols, and quality standards for stroke management to ensure consistent and high-quality care across the region.” 

In 2013, a group of strokeologists and neurointerventionalists came together to improve ischaemic and hemorrhagic stroke services in the region, founding the Middle East and North Africa Stroke and Interventional Neurotherapies Organization (MENA-SINO). In addition to providing education, endovascular thrombectomy training, and awareness for stroke care providers, the group also conducts research to further locally-relevant solutions for reducing the burden of stroke on the region’s healthcare systems while building a database of stroke diagnoses to learn from.  

These initiatives can help gather comprehensive data on stroke cases, treatment outcomes, and quality indicators, says Aster DM’s Arshanapalai. “It’s about knowledge exchange, best practice sharing, and capacity building. This can contribute to standardising stroke management protocols, implementing evidence-based guidelines, and enhancing the overall quality of stroke care in the MENA region.” 

The region is already an early technology adopter in stroke diagnosis, acute care, and rehabilitation, bolstered by supporting public healthcare spending and policies. A future area for growth is preventative stroke care, which starts with building public awareness. Increased awareness of stroke symptoms and the need for rapid admission to the hospital can improve patient outcomes. Stakeholders can advance this area of stroke care by working together, sharing resources, and fostering partnerships so that people are aware of the importance of getting care in the vital ‘golden hour'.   

Back to Management

Skin cancer is the uncontrolled, abnormal growth and multiplication of cells and is often caused by extensive or prolonged exposure to the sun's harmful ultraviolet (UV) rays. Nearly one in five people develop skin cancer sometime in their life, and it can affect people of all skin tones. The good news is that nearly all skin cancers can be cured if diagnosed and treated early.  

According to a 2019 report by the UAE National Cancer Registry, skin cancer is the fourth most common cancer in the UAE after breast, thyroid, and colorectal cancers. It is the second leading cause of cancer among men and sixth among women. 

Related: Skin Cancer Growing Public Concern in the UAE

The three main types of skin cancer are basal cell carcinoma, squamous cell carcinoma, and melanoma. While basal cell and squamous cell carcinomas are the most common and usually not life-threatening, melanoma is a more aggressive form of skin cancer that can spread to other organs and is difficult to treat if it is not caught early. 

Cleveland Clinic Abu Dhabi’s oncology and dermatology teams share more details on the types of skin cancer and ways to prevent them. 

Related: The growing prevalence of skin cancer among men

Dr. Ahmed Aldhaheri, Staff Physician in the Medical Subspecialty Institute

 

Dr. Ahmed Aldhaheri, Staff Physician in the Medical Subspecialty Institute, says, “While there are various treatment options available for skin cancer, it is important to focus on prevention, as it is always better than treatment. The first line of defence to prevent skin cancer is to protect your skin from the sun’s harmful UV rays. This can be done by wearing protective clothing such as long-sleeved shirts, long pants, and wide-brimmed hats, as well as sunglasses that are UV-protected. Additionally, applying sunscreen with an SPF of at least 30 and wearing lip balm, even on cloudy days, should be a part of your daily routine. Sunscreen should be applied generously and reapplied every two hours or after swimming or exercising in the sun, as you are prone to sweat.”  

Avoiding the sun during peak hours (between 10 am and 4 pm), as the sun's rays are strongest during this time, is also advisable. Seeking shade and using a beach umbrella or other sunshade can also help protect you from direct sunlight. 

Dr. Fatima Al Faresi, Staff Physician in the Medical Subspecialties Institute

 

“Tanning beds have become a growing fad across the world as people seek that ‘sun-kissed glow’. However, these should be avoided, as they emit harmful UV radiation. They are especially dangerous for young people, as they can increase their risk of developing skin cancer later in life,” Dr. Fatima Al Faresi, Staff Physician in the Medical Subspecialties Institute, continues, “While prevention is the best approach, it is also important to detect skin cancer early so that it can be treated effectively. Everyone should examine their skin regularly for any signs of skin abnormality or changes which can help detect the disease early when it is most treatable. This includes checking moles and other skin lesions for any changes in size, shape, or colour.” 

Dr. Raghda Al Maashari, Staff Physician, Dermatology, Medical Subspecialties Institute

 

Dr. Raghda Al Maashari, Staff Physician, Dermatology, Medical Subspecialties Institute, says, “We usually recommend following the ABCDE rule, which helps identify abnormalities and red flags related to skin cancer.” The ABCDE rule alerts you to signs to watch for: 

- Asymmetry: Irregular shape 

- Border: Blurry or irregularly shaped edges 

- Colour: Mole with more than one colour 

- Diameter: Larger than a pencil eraser (6 mm) 

- Evolution: Enlarging, changing in shape, colour, or size (this is the most important sign) 

“Your skin is the largest organ in your body and needs as much attention as any other health concern. What may seem like an innocent cosmetic imperfection may not be. Therefore, performing regular skin self-checks is important for everyone, especially if you fall in the high-risk zone.”  

Cleveland Clinic Abu Dhabi’s skin cancer programme consults patients with various oncology needs. Annual skin examination is recommended for anyone who has had: 

- Previous melanoma, skin cancer, or precancerous lesions. 

- A first-degree relative (parent, sibling or child) with melanoma. 

- Numerous or unusual moles. 

- History of tanning bed use. 

- History of blistering sunburns. 

- Regular sun exposure. 

- An organ transplantation. 

Also, keep in mind that having a family history of the disease can increase your risk of developing it. 

Dr. Ahmad Matalkah, Staff Physician and Surgical Oncologist at the Digestive Disease Institute and Oncology Institute

 

Dr. Ahmad Matalkah, Staff Physician and Surgical Oncologist at the Digestive Disease Institute and Oncology Institute concludes, “Your doctor may advise doing a biopsy to identify if the lesion is malignant and, if so, what kind of skin cancer it is. A biopsy identifies the exact type of cancer and its staging, that is, how far the cancer has progressed. This information, alongside other factors such as the age of the patient and overall health, allows us to determine the best treatment plan.”  

But foremost, taking proactive steps to protect your skin can ensure a healthier future and a reduced risk of skin cancer.  

Back to Clinical

Recent medical technology developments are revolutionising how healthcare providers approach the challenge of diagnosing and treating thyroid nodules and their associated conditions.  

From the use of artificial intelligence (AI) in diagnosing thyroid cancer to the advent of laser ablation for benign nodules, patients now have access to more efficient and less invasive procedures. This World Thyroid Day, which is marked globally on May 25, experts say that these advancements improve accuracy and spare individuals unnecessary surgeries and lifelong medication dependence.  

Related: Treating thyroid disorders through AI-powered innovations

Thyroid cancer is a growing concern, particularly in the UAE, where it ranks as the top endocrine malignancy and the second most common cancer in women. However, diagnosing thyroid disease, especially cancer, can be challenging due to the limitations of traditional methods. The reliance on ultrasound and fine-needle aspiration biopsies (FNAB) for detection and interpretation often results in indeterminate diagnoses and unnecessary surgeries. 

To overcome these limitations, AI is now playing a vital role in thyroid cancer diagnosis. AI algorithms can analyse thyroid images, detect abnormalities, and interpret the likelihood of malignancy more accurately. At GluCare.Health specialists have successfully integrated AI into their diagnostic protocols. Dr. Milena Caccelli, Specialist Endocrinologist at GluCare.Health, highlights the impact: “Our approach has helped us reduce the number of unnecessary invasive procedures and provide patients with a more convenient and prompt experience.” 

Related: Endoscopic Technique Allows Removal of Thyroid and Parathyroid With No Visible Scar

Dr. Milena Caccelli, Specialist Endocrinologist at GluCare

 

By using AI tools, healthcare providers can significantly reduce the need for FNABs, ensuring that patients only undergo invasive procedures when necessary. This approach improves diagnostic accuracy, prognosis, and medical interpretation while minimising discomfort and the risk of complications. AI-generated diagnostics have become a valuable preventative health tool, empowering physicians to detect and monitor thyroid nodules more effectively. 

The traditional treatment approach for benign thyroid nodules involves surgical removal of the thyroid gland or a lifelong dependency on medications. However, a breakthrough technique called laser ablation is changing the landscape of thyroid nodule treatment. Doctors at Sheikh Khalifa Medical City (SKMC) successfully performed laser ablation on a 48-year-old woman with multiple nodules last year. 

In an announcement, Dr. Shaik Irfan Basha, Consultant Otorhinolaryngology and Head & Neck Surgery at SKMC, said: “This technique is performed while the patient is conscious, under local anaesthesia. A thin needle, less than one millimetre in diameter, is inserted into the target thyroid nodule under ultrasound guidance. Laser treatments are performed through the needle, and the amount of energy delivered is planned based on the size of the nodule."  

He added that the procedure is minimally invasive, and patients typically recover within two hours, allowing for same-day discharge and quick resumption of daily activities. 

Laser ablation offers numerous benefits, including avoiding surgery, eliminating medication dependency, and preserving the thyroid gland's function. This relatively new procedure is effective, reproducible, well-tolerated, and associated with a low risk of complications. It provides a viable alternative for patients who prefer to avoid surgery or have concerns about lifelong medication usage. 

The thyroid nodule diagnosis and treatment landscape are rapidly evolving with advancements in AI-driven diagnostics and laser ablation techniques. Integrating AI into standard diagnostic protocols improves accuracy and reduces the need for invasive procedures, sparing patients unnecessary discomfort and surgeries.  

Back to Management

 

Access the must-read eBook on AI here to discover perspectives on its transformative role in the healthcare industry.

According to the Centre for Disease Control (CDC), breast cancer is the second most common malignancy to affect women in the US, after skin cancer. In 2019, 264,121 women were diagnosed with breast cancer, of which 42,280 women lost their lives to it, per the latest available data. However, hope is on the horizon.  

Latest advances in medical equipment, treatment protocols, and effective drugs are poised to treat aggressive breast cancers more effectively. Let’s look at some of the latest developments: 

A growing awareness that aggressive breast cancer is a systemic disease 

Related: Busting the myth of male breast cancer

There is increasing awareness among researchers and clinicians that breast cancer is not limited to breasts alone. It is a systemic disease that can affect the entire body. Hence, doctors are now of the view that a systemic approach is necessary to stop aggressive breast cancer from spreading to unaffected areas. This approach uses antibody treatments and immunotherapies to target cancer cells across the body. The idea is to stop the tumour cells from spreading to adjoining areas. Hence, precision medicine that targets specific cancer cells is currently under research.  

Regardless of the approach, breast cancer can severely reduce the quality of life. Consequently, physicians are also exploring several ways to improve women’s quality of life.  

Growth of drugs with fewer side effects and a focus on scar reduction 

Related: Advanced technologies and AI can help beat breast cancer

Although no two cancers are alike, newer drugs and advanced equipment are simplifying treating aggressive breast cancer. It’s been seen that drugs such as Xeloda and Neulasta are more effective and have fewer side effect profiles. Xeloda blocks residual tumour cells so that cancer does not spread to other organs, which results in metastasised growth.  

In addition, both surgery and radiation are also evolving immensely. They are now less invasive and more effective at treating aggressive breast cancers.  

As cancer surgery is known to destroy many nerves, there is a growing interest in nerve reconnection, scar reduction, and aesthetic enhancement. Skin-sparing mastectomies and reconstruction treatments are also being leveraged to help reduce the psychological distress women with aggressive breast cancers experience while preventing cancer recurrence.  

Adopting advanced treatment protocols to treat aggressive breast cancer 

Previously, oncologists used a combination of radiosurgery, chemotherapy, and double mastectomies to tackle the spread of tumour cells in specific areas. However, advances in chemotherapy, radiation, and surgery are working toward making cancer treatment less invasive and life-changing.  

Back to Clinical

As one of the largest populations in Africa, Nigeria has a significant burden of disease, which creates a strong demand for healthcare services. The country is also facing brain drain, which presents a leaner healthcare force, and a growing middle class in the population of social hierarchy. However, an increasing number of people have access to mobile phones and the internet, which provides a platform for the development and delivery of healthtech solutions. 

The above-mentioned trend of events are influencing the adoption of healthtech trends in Nigeria in 2023, as more healthcare providers and patients are embracing digital health tools to reduce the burden on a stretched healthcare workforce and are helping to address the  healthcare needs of the increasing population, while improving healthcare outcomes. This is also improving access to healthcare and increasing efficiency. 

Related: MEA’s leading digital healthcare platform Vezeeta eyes Sub-Saharan Africa growth from bases in Kenya and Nigeria

However, it is not sufficient to laud the growth potential of the healthtech market. In this article, we take an introspective look into what solutions have the potential to transform delivery of care and how they will help stakeholders in the healthtech market make more informed decisions that might metamorphose into investments. 

With the WHO marking its 75th anniversary and calling for a  renewed drive for health equity, this will drive most healthtech solutions to focus on accessibility and affordability because it also corresponds with the present socio-economic reality of the country.  

Related: Telehealth startup Vezeeta eyes Sub-Saharan Africa growth from Kenya and Nigeria bases

Below, we explore some areas in the healthtech market that are gaining traction: 

- Mobile health (mHealth) 

With the increasing use of mobile phones in Nigeria, mHealth applications are expected to become more popular in 2023. These applications will help patients monitor their health and communicate with healthcare providers, which could improve patient outcomes and reduce healthcare costs. For example, a fast-growing startup, mDoc, connects people to a multi-disciplinary team of providers who have been trained in person-centred care to support them in managing their disease.  

The CEO of mDoc, Nneka Mobisson, says “We’ve had over 100,000 members enrolled on the Complete Health platform, 87 per cent of which are women. The majority make less than US$3 a day, so we’re reaching the most vulnerable populations. We’ve also trained over 8,000 healthcare workers, with partner hubs across Nigeria and Kenya, in managing maternal health, chronic disease, cancer, and more. We’ve seen how a bean grinder who lives in a room with 10 other people and buys two individual blood pressure pills a week can track their blood pressure and learn how to exercise within their means.” 

This is just an example of the work presently going on, which will herald the greater innovations ahead.  

- Solutions that minimise the administrative burden on doctors and other healthcare workers  

It is a known fact that the Nigerian healthcare system has the challenge of brain drain. Solutions developed in this domain will thrive as they support healthcare workers across the board and reduce human resource burnout.  

The solutions will span through telemedicine, which allows patients to consult with doctors and other healthcare professionals remotely. This could improve access to healthcare for people in remote areas and reduce the burden on hospitals. In addition, Health Information Exchange will help appropriately access and securely share a patient's medical information and reduce duplication of tests and treatments with a motive to improve patient outcomes and lower healthcare costs. 

- B2B healthtech companies have a high potential to hold a significant share of the market 

Companies that offer B2B solutions that improve healthcare delivery increase efficiency, reduce costs, and improve patient outcomes may have a significant impact and receive strong demand from healthcare providers and healthcare seekers. This negates the possible challenge of navigating complex regulatory frameworks to operate in the country and the possibility of initial resistance by healthcare providers or patients. However, the success of B2B healthtech companies in Nigeria in 2023 and beyond will depend on various factors, including the quality of their products, the ability to navigate regulatory hurdles, establishing partnerships and collaborations with the Nigerian healthcare ecosystem and the ability to deal with cultural barriers. 

Overall, considering the rapid advancement in technology, the future of healthtech in Nigeria is promising. It has the potential to address the country's healthcare challenges, transform healthcare delivery and improve healthcare outcomes for its large and growing population. 

Back to Technology

As one of the most common chronic diseases worldwide, diabetes affects millions of people globally, according to the World Health Organization. However, thanks to the rapid advancement of technology, there has been a rise in the development of diabetic technology or “diabetic tech” that can help patients better manage their condition and improve their quality of life.

Managing diabetes requires a combination of lifestyle changes, medication management, and regular monitoring. One of the most significant advancements in diabetic tech is continuous glucose monitoring (CGM) devices. These devices monitor patients' glucose levels in real-time and alert them when they are too high or too low. This technology allows patients to monitor their glucose levels more accurately and adjust their diet or medication as needed, according to a study titled: Diabetes digital app technology: benefits, challenges, and recommendations.

Related: Wearable medical devices for diabetes and cardiovascular diseases gain traction

Another advancement in diabetic tech is insulin pumps. These devices deliver insulin continuously and eliminate the need for multiple daily injections. Insulin pumps allow patients to better manage their glucose levels, especially during physical activity or when sleeping, as that is when glucose levels fluctuate.

To tackle this chronic condition, Innovation Zed, an Irish R&D company specialising in designing, developing, and manufacturing medical devices, recently formed a strategic partnership with Dubai’s GluCare.Health, to launch a metabolic disease management platform.

Related: Diabetes prevention remains UAE’s top priority

Under the InsulCheck brand, Innovation Zed offers a range of intelligent add-on devices that connect to a dedicated app. These devices facilitate automatic logging and secure storage of crucial information related to injection history, specifically designed for Multiple Daily Injection (MDI) users. This integration can support platforms such as GluCare.Health to continuously monitor and manage insulin-dependent patients with greater precision.

Real-time updates on insulin doses and timings enable healthcare professionals to gain insights into patients' insulin information in conjunction with glucose and other relevant data parameters. This approach provides a comprehensive overview of the patient's health status and requirements, leading to more informed and personalised care.

Improving patient outcomes

Telemedicine and telemonitoring are also changing the landscape of diabetes care. Patients can now monitor their glucose levels and communicate with healthcare providers remotely, reducing the need for in-person visits. This technology can also provide real-time data to healthcare providers, allowing them to make more informed decisions about patient care.

Diabetic tech is not just changing patient care but also transforming the way hospitals work. Hospital systems are beginning to integrate diabetic tech into their electronic health records (EHRs) to improve patient outcomes and streamline workflows. EHRs that include diabetic tech data can provide a complete picture of a patient's health, allowing for personalised care and treatment plans.

One example of this is the use of artificial intelligence (AI) in diabetic care. AI algorithms can analyse vast amounts of data, including patient data from diabetic tech devices, to identify patterns and provide personalised treatment recommendations. This technology can potentially improve patient outcomes and reduce healthcare costs by identifying high-risk patients before they require hospitalisation.

Furthermore, the use of diabetic tech has the potential to improve patient education and self-management. Apps and other digital tools can provide patients with personalised education and support, helping them better understand and manage their condition. This technology can also help patients track their progress and set goals for improved diabetes management.

In conclusion, diabetic tech has the potential to revolutionise the way patients manage their diabetes and how healthcare providers deliver care. With continuous technological advancements, diabetic tech will continue to improve patient outcomes, reduce healthcare costs, and transform the industry. As healthcare systems continue to integrate diabetic tech into their workflows, patients will have access to more personalised care, better education, and more advanced treatments.

 

Back to Technology

 

 

References

https://www.who.int/news-room/fact-sheets/detail/diabetes

https://www.diabeteseducator.org/research/adces-diabetes-technology-focused-research

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197631/

https://pubmed.ncbi.nlm.nih.gov/31802144/

https://www.aafp.org/pubs/afp/issues/2022/0300/p281.html

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610600/

https://pubmed.ncbi.nlm.nih.gov/32325045/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139833/